Related Experiment Video
Updated: Jul 12, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Update on the botulinum neurotoxins.
1Division of Dermatology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Botulinum neurotoxins (BTX) are increasingly used for therapeutic purposes, with expanded FDA approvals for conditions like cervical dystonia and cosmetic applications. Improved formulations have reduced side effects and secondary resistance, enhancing patient outcomes.
Area of Science:
- Neurology
- Pharmacology
- Cosmetic Science
Background:
- Botulinum neurotoxins (BTX) are potent therapeutic agents with a growing range of clinical applications.
- Current FDA-approved BTX products include BOTOX (BTX-A) and Myobloc (BTX-B).
Purpose of the Study:
- To highlight the expanding clinical indications for botulinum neurotoxins.
- To discuss the safety and efficacy of BTX therapies.
- To address concerns regarding side effects and resistance.
Main Methods:
- Review of clinical applications and regulatory approvals for BTX.
- Analysis of factors influencing the incidence of secondary resistance to BTX.
Main Results:
- BTX-A and BTX-B are approved for cervical dystonia treatment in the US.
- BOTOX is approved in Canada for glabellar frown lines, with expected US FDA approval.
- Reduced non-toxic protein in BOTOX has significantly decreased secondary resistance.
Conclusions:
- The clinical use and marketing of BTX are expanding rapidly.
- Increased clinical experience is mitigating concerns about BTX risks and side effects.
- Formulation improvements have enhanced the long-term effectiveness of BTX therapies by reducing resistance.
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Bacterial Toxins
Tetanus
Botulism

